Project
BASE: An open label, randomized study to compare the efficacy of Certolizumab pegol (CZP) plus a dynamic or fixed dose treatment strategy in patients with Rheumatoid Arthritis, a phase II study
Completed - recruitment closed ยท 2013 until 2023
Rubbert-Roth Andrea, Bartz-Batliner Mira
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed - recruitment closed
Start Date
2013
End Date
2023
Financing
Industry
Keywords
Lupus, Belimumab
Brief description/objective
Belimumab bei Patienten mit Lupus erythematodes, Erfassung von Nebenwirkungen